Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Quick Stats
Jan 30, 202656.0
AI Score
HOLD0.44
Volume Ratio
Feb 26, 2026
Next Earnings
13
+ve Days (30d)
14
-ve Days (30d)
JSPR Stock Summary
Last updated Jan 30, 2026
JSPR is currently trading at $1.48, positioned below its 200-day moving average of $3.11, suggesting bearish momentum. The stock has a 52-week range of $1.39 to $7.19.
Technical Analysis: The 50-day moving average stands at $1.71, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 40.136, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.147, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates JSPR at 56.0/100 with a HOLD recommendation.
JSPR (Jasper Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 40.136 |
| CMF (20) | -0.147 |
| ROC (10) | -2.632 |
| ADX (14) | 10.989 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.063 |
| AROONOSC (14) | -7.143 |
| WILLAMS %R (14) | -73.585 |
| MFI (14) | 38.533 |
JSPR Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
JSPR Price vs Max Options Open Interest
JSPR Max Change In Options Open Interest
JSPR Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JSPR Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JSPR Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JSPR Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Jasper Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
JSPR Moving Averages Analysis
JSPR (Jasper Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 1.55 |
| 20 | 1.62 |
| 30 | 1.68 |
| 50 | 1.71 |
| 100 | 2.0 |
| 200 | 3.11 |
JSPR Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 43.4 million |
| Earnings/Share ($) | -5.82 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -4.904 |
| EPS Estimate Next Year ($) | -3.092 |
| WallStreet Target Price ($) | 9.8 |
| Most Recent Quarter |